Lenvatinib in combination with transarterial chemoembolization for treatment of unresectable hepatocellular carcinoma (uHCC): a retrospective controlled study

PURPOSE: To compare the efficacy and safety of combined treatment with lenvatinib and transarterial chemoembolization (TACE) versus TACE only in patients with unresectable hepatocellular carcinoma (uHCC). METHODS: Of the 120 patients enrolled in this study, 60 patients received treatment with TACE o...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Hepatol Int
Main Authors: Fu, Zhigang, Li, Xiaowei, Zhong, Jiaming, Chen, Xiaoxia, Cao, Kunkun, Ding, Ning, Liu, Li, Zhang, Xiaoli, Zhai, Jian, Qu, Zengqiang
Formato: Artigo
Idioma:Inglês
Publicado: Springer India 2021
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8286947/
https://ncbi.nlm.nih.gov/pubmed/33877527
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12072-021-10184-9
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares